Bempegaldesleukin (<scp>BEMPEG</scp>; <scp>NKTR</scp>‐214) efficacy as a single agent and in combination with checkpoint‐inhibitor therapy in mouse models of osteosarcomaMarlene Hennessy, Nancy Gordon, Kumar Felix et al.|International Journal of Cancer|2020Cited by 20